3D Systems (DDD) Cantor Fitzgerald Global Technology Conference summary

Industry trends and technology evolution

• 3D printing is rapidly transforming dentistry, with applications in straightening, protection, repair, and full replacement of teeth, and the market for dentures is expected to be a major growth area due to an aging population.

• Direct printing of dental aligners is anticipated to open new markets and further disrupt traditional wire braces, pending FDA approval of new materials.

• Healthcare applications, especially personalized bone and joint replacements, are expanding from planned surgeries to trauma and emergency care, with future growth expected in other joints and eventually organ printing.

• Production applications now account for at least 75% of sales, with a strategic focus on high-potential customers and markets that can scale to $100 million or more.

• The company has insourced manufacturing to the U.S. for quality and tariff insulation, with most polymer printers now assembled domestically.

Key partnerships, contracts, and product launches

• A five-year, $250 million contract was signed with Align for material sales, the largest in company history, with four years remaining.

• New dental products, including night guards and monolithic dentures, are expected to hit the market and income statement within the next 12 months, with dentures already FDA approved.

• The company is launching a new printer for local dental labs and chairside use this summer, targeting rapid, on-demand production.

• The Hexagon acquisition of Geomagic software is expected to close between the end of Q1 and May, bringing in $123 million in cash before taxes.

Financial outlook and operational focus

• Gross margins are currently around 40% and are expected to trend toward 50% as production volumes and consumable revenues increase.

• Aggressive cost reduction and footprint simplification are planned for 2025–2026, aiming for profitability and positive free cash flow at current sales levels within two to three years.

• The company is shifting from heavy R&D investment to a focus on cost control, SG&A reduction, and operational efficiency.

• Industry consolidation is expected, with smaller players likely to exit and their technology or revenue redistributed among larger firms.